Xenon Pharmaceuticals to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

Rhea-AI Summary

Xenon Pharmaceuticals Inc. (Nasdaq:XENE) announced its participation in the 11th Annual SVB Leerink Global Healthcare Conference on February 17, 2022. The company will conduct one-on-one investor meetings and a virtual fireside chat.

The chat is scheduled for 5:00-5:30 pm ET and will be presented by Ian Mortimer, the President and CEO. Attendees can access details and webcasts on the company’s website after the event.

Xenon is focused on developing innovative treatments for neurological disorders, particularly epilepsy.

BURNABY, British Columbia, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced its participation in one-on-one investor meetings and a virtual fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference.

Fireside Chat Details:
Date: Time: Presenter:	Thursday, February 17, 2022 5:00-5:30 pm ET Ian Mortimer, President and CEO

The above listed dates and times are subject to change. Details on company presentations and webcasts can be found on the “Investors” section of Xenon's website at investor.xenon-pharma.com. When available, webcasts will be posted for replay following the event.

About Xenon Pharmaceuticals Inc.

We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com

FAQ

When is Xenon Pharmaceuticals' virtual fireside chat?

Xenon's virtual fireside chat is scheduled for February 17, 2022, from 5:00-5:30 pm ET.

Who will present at the SVB Leerink Global Healthcare Conference for XENE?

Ian Mortimer, President and CEO, will present at the conference.

What is the focus of Xenon Pharmaceuticals?

Xenon Pharmaceuticals is dedicated to developing therapies for neurological disorders, with a focus on epilepsy.

Where can I find more information about the Xenon event?

Details about the event and webcasts can be found in the Investors section of Xenon’s website.

What type of meetings is Xenon Pharmaceuticals participating in at the conference?

Xenon Pharmaceuticals is participating in one-on-one investor meetings and a virtual fireside chat.